不妊治療サービス市場：サービスタイプ、エンドユーザー、不妊治療、技術別-2025-2030年の世界予測

不妊治療サービス市場は、2023年に439億3,000万米ドルと評価され、2024年には475億5,000万米ドルに達すると予測され、CAGR 8.11％で成長し、2030年には758億4,000万米ドルに達すると予測されています。

不妊治療サービスには、体外受精（IVF）、子宮内人工授精（IUI）、その他の生殖補助医療技術（ART）など、個人やカップルの妊娠を助けることを目的とした幅広い治療が含まれます。これらのサービスの必要性は、ライフスタイルの変化、妊娠の遅れ、生殖医療に対する意識の高まりに関連した不妊率の増加から生じています。用途は主に医療で、不妊の課題、遺伝的疾患、親になることを望む同性カップルを支援します。最終用途分野には、病院、不妊治療クリニック、手術センターなどが含まれます。市場は、ARTの技術的進歩、一般市民の意識の高まり、政府の支援策、晩婚化を選択する高齢化によって牽引されています。個別化された不妊治療、凍結保存技術の向上、生殖の健康状態をモニターするためのデジタルヘルスソリューションに新たなビジネスチャンスがあります。これらをより効果的に活用するために、企業は体外受精の成功率の向上と予測診断のためのAIの統合に重点を置いた研究開発に投資すべきです。しかし、同市場は、高額な手続き費用、限られた保険適用範囲、ARTをめぐる倫理的懸念といった限界に直面しています。さらに、特定地域における規制上の課題や社会文化的タブーが、引き続き市場拡大の妨げとなっています。キャリア志向の人々の間で卵子・精子凍結の需要が高まっていることも、成長の可能性を示しています。非侵襲的診断ツールや遺伝子スクリーニングの革新は、治療の成功と患者の快適さの可能性をさらに広げる可能性があります。市場参入企業には、手頃な価格と品質を維持しながら、これらの課題を克服することが求められます。競合市場であり、主に医学研究の進歩に牽引される市場であるため、バイオテクノロジー企業とヘルスケアプロバイダーとの継続的なコラボレーションは、技術革新を促進し、消費者の嗜好に関する洞察を提供し、ビジネス成長の道を開く可能性があります。

市場力学：急速に進化する不妊治療サービス市場の主要市場インサイトを公開

不妊治療サービス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の不妊症の蔓延と生殖補助医療技術に対する意識の高まり
  • 不妊治療へのアクセスを向上させるための政府の取り組みと支持的な規制枠組み
  • 不妊治療と診断の技術的進歩による成功率の向上
  • 高度不妊治療にかかる高額な費用と、様々な地域における限られた償還政策
• 市場抑制要因
  • 世界の不妊治療サービス市場に影響を与える経済的・規制的課題
  • 高度不妊治療の採用を妨げる技術的・倫理的ジレンマ
• 市場機会
  • 男性不妊問題に対する認識と受容の高まりが市場成長を促進
  • 新興市場における手頃な不妊治療の利用可能性の増加
  • 海外での費用対効果の高い治療オプションによる不妊治療ツーリズムの拡大
• 市場の課題
  • 特定の国における厳しい規制により、特定の不妊治療や不妊技術の使用が制限されています。
  • 体外受精やその他のART治療における高額な治療費

ポーターの5つの力：不妊治療サービス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：不妊治療サービス市場における外部からの影響の把握

外部マクロ環境要因は、不妊治療サービス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析不妊治療サービス市場における競合情勢の把握

不妊治療サービス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス不妊治療サービス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、不妊治療サービス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨不妊治療サービス市場における成功への道筋を描く

不妊治療サービス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 不妊症の増加と生殖補助技術に対する意識の世界の高まり
    • 不妊治療へのアクセスを改善するための政府の取り組みと支援的な規制枠組み
    • 不妊治療と診断における技術の進歩により成功率が向上
    • 高度な不妊治療の高額な費用と、さまざまな地域での限られた償還ポリシー
  • 抑制要因
    • 経済的および規制上の課題が世界のライナー治療サービス市場の到達範囲と受け入れに影響を与える
    • 高度な不妊治療の導入を妨げる技術的および倫理的ジレンマ
  • 機会
    • 男性不妊の問題に対する認識と受容の高まりが市場の成長を牽引
    • 新興市場における手頃な不妊治療の利用可能性の拡大
    • 海外での費用対効果の高い治療オプションによる不妊治療ツーリズムの拡大
  • 課題
    • 一部の国では、特定の不妊治療や技術の使用を制限する厳しい規制がある
    • 体外受精やその他のART治療にかかる高額な費用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 不妊治療サービス市場：サービスタイプ別

• 卵子提供体外受精
  • 新規ドナー
  • 凍結ドナー
• 体外受精と顕微授精
• 代理出産

第7章 不妊治療サービス市場：エンドユーザー別

• 不妊治療クリニック
• 病院
• 調査機関
• 外科センター

第8章 不妊治療サービス市場不妊治療別

• 内分泌内分泌
• 体外受精
• 薬物治療
• 手術

第9章 不妊治療サービス市場：技術別

• 人工授精
• 凍結胚移植（FET）
• 体外受精顕微授精
• 着床前遺伝子診断（PGD）

第10章 南北アメリカの不妊治療サービス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の不妊治療サービス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの不妊治療サービス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. AbbVie Inc.
• 2. Aspira Women's Health Inc.
• 3. Celmatix Inc.
• 4. Cook Medical Group, Inc.
• 5. CooperSurgical, Inc.
• 6. Ferring Pharmaceuticals
• 7. FUJIFILM Irvine Scientific, Inc.
• 8. Genea Limited
• 9. Illumina, Inc.
• 10. Irvine Scientific Sales Company, Inc.
• 11. Kaiser Permanente
• 12. Mayo Clinic
• 13. Merck KGaA
• 14. Natera, Inc.
• 15. Prelude Fertility, Inc.
• 16. Progyny, Inc.
• 17. Thermo Fisher Scientific Inc.
• 18. Vitrolife AB

LIST OF FIGURES

• FIGURE 1. FERTILITY SERVICES MARKET RESEARCH PROCESS
• FIGURE 2. FERTILITY SERVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL FERTILITY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL FERTILITY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL FERTILITY SERVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL FERTILITY SERVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. FERTILITY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. FERTILITY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. FERTILITY SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL FERTILITY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL FERTILITY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. FERTILITY SERVICES MARKET DYNAMICS
• TABLE 7. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FRESH DONOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FROZEN DONOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL FERTILITY SERVICES MARKET SIZE, BY IVF WITH ICSI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SURROGACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL FERTILITY SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL FERTILITY SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL FERTILITY SERVICES MARKET SIZE, BY IUI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL FERTILITY SERVICES MARKET SIZE, BY IVF, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL FERTILITY SERVICES MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER (FET), BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL FERTILITY SERVICES MARKET SIZE, BY IVF ICSI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL FERTILITY SERVICES MARKET SIZE, BY PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD), BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. CANADA FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 47. CANADA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. CANADA FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 49. CANADA FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. CHINA FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. CHINA FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 74. CHINA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. CHINA FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 76. CHINA FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. INDIA FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 78. INDIA FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 79. INDIA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. INDIA FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 81. INDIA FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. ITALY FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 164. ITALY FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 165. ITALY FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 166. ITALY FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 167. ITALY FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. POLAND FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 184. POLAND FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 185. POLAND FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. POLAND FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 187. POLAND FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. QATAR FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 189. QATAR FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 190. QATAR FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 191. QATAR FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 192. QATAR FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM FERTILITY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM FERTILITY SERVICES MARKET SIZE, BY DONOR EGG IVF, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM FERTILITY SERVICES MARKET SIZE, BY FERTILITY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM FERTILITY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 238. FERTILITY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 239. FERTILITY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Fertility Services Market was valued at USD 43.93 billion in 2023, expected to reach USD 47.55 billion in 2024, and is projected to grow at a CAGR of 8.11%, to USD 75.84 billion by 2030.

Fertility services encompass a broad range of treatments aimed at aiding individuals and couples in achieving conception, covering procedures such as in vitro fertilization (IVF), intrauterine insemination (IUI), and other assisted reproductive technologies (ART). The necessity for these services stems from increasing infertility rates linked to lifestyle changes, delayed pregnancies, and rising awareness about reproductive health. Applications are predominantly medical, aiding those with infertility challenges, genetic conditions, or same-sex couples desiring parenthood. End-use segments include hospitals, fertility clinics, and surgical centers. The market is driven by technological advancements in ART, increasing public awareness, supportive government initiatives, and an aging population choosing to have children later in life. Emerging opportunities lie in personalized fertility treatments, improved cryopreservation techniques, and digital health solutions for monitoring reproductive health. To better capitalize on these, businesses should invest in R&D focused on enhancing IVF success rates and integrating AI for predictive diagnostics. However, the market faces limitations such as high procedural costs, limited insurance coverage, and ethical concerns surrounding ART. Additionally, regulatory challenges and socio-cultural taboos in certain regions continue to hinder market expansion. The growing demand for egg and sperm freezing among career-oriented individuals also indicates potential for growth. Innovations in non-invasive diagnostic tools and genetic screening could further extend the possibilities for treatment success and patient comfort. Market participation requires navigating these challenges while maintaining affordability and quality. The fertility services market is competitive and primarily driven by advancements in medical research, thus ongoing collaborations between biotech firms and healthcare providers could foster technological innovations and offer insights into consumer preferences, paving the way for business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fertility Services Market

The Fertility Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of infertility issues and rising awareness about assisted reproductive technologies globally
  • Government initiatives and supportive regulatory framework to improve fertility treatment accessibility
  • Technological advancements in fertility treatments and diagnostics enhancing success rates
  • High cost of advanced fertility treatments and limited reimbursement policies across various regions
• Market Restraints
  • Economic and regulatory challenges impacting the global fertility services market's reach and acceptance
  • Technological and ethical dilemmas hindering the adoption of advanced fertility treatments
• Market Opportunities
  • Rising awareness and acceptance of male infertility issues driving market growth
  • Increasing availability of affordable fertility treatments in emerging markets
  • Expansion of fertility tourism due to cost-effective treatment options abroad
• Market Challenges
  • Stringent regulations in certain countries limiting the use of certain fertility treatments and technologies
  • High cost of treatment of IVF and other ART procedures

Porter's Five Forces: A Strategic Tool for Navigating the Fertility Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fertility Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fertility Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fertility Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fertility Services Market

A detailed market share analysis in the Fertility Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fertility Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fertility Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fertility Services Market

A strategic analysis of the Fertility Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fertility Services Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aspira Women's Health Inc., Celmatix Inc., Cook Medical Group, Inc., CooperSurgical, Inc., Ferring Pharmaceuticals, FUJIFILM Irvine Scientific, Inc., Genea Limited, Illumina, Inc., Irvine Scientific Sales Company, Inc., Kaiser Permanente, Mayo Clinic, Merck KGaA, Natera, Inc., Prelude Fertility, Inc., Progyny, Inc., Thermo Fisher Scientific Inc., and Vitrolife AB.

Market Segmentation & Coverage

This research report categorizes the Fertility Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Service Type, market is studied across Donor Egg IVF, IVF with ICSI, and Surrogacy. The Donor Egg IVF is further studied across Fresh Donor and Frozen Donor.
• Based on End User, market is studied across Fertility Clinics, Hospitals, Research Institutes, and Surgical Centers.
• Based on Fertility Treatment, market is studied across IUI, IVF, Medication, and Surgery.
• Based on Technology, market is studied across Artificial Insemination, Frozen Embryo Transfer (FET), IVF ICSI, and Pre-Implantation Genetic Diagnosis (PGD).
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of infertility issues and rising awareness about assisted reproductive technologies globally
    • 5.1.1.2. Government initiatives and supportive regulatory framework to improve fertility treatment accessibility
    • 5.1.1.3. Technological advancements in fertility treatments and diagnostics enhancing success rates
    • 5.1.1.4. High cost of advanced fertility treatments and limited reimbursement policies across various regions
  • 5.1.2. Restraints
    • 5.1.2.1. Economic and regulatory challenges impacting the global fertility services market's reach and acceptance
    • 5.1.2.2. Technological and ethical dilemmas hindering the adoption of advanced fertility treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising awareness and acceptance of male infertility issues driving market growth
    • 5.1.3.2. Increasing availability of affordable fertility treatments in emerging markets
    • 5.1.3.3. Expansion of fertility tourism due to cost-effective treatment options abroad
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulations in certain countries limiting the use of certain fertility treatments and technologies
    • 5.1.4.2. High cost of treatment of IVF and other ART procedures
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Fertility Services Market, by Service Type

• 6.1. Introduction
• 6.2. Donor Egg IVF
  • 6.2.1. Fresh Donor
  • 6.2.2. Frozen Donor
• 6.3. IVF with ICSI
• 6.4. Surrogacy

7. Fertility Services Market, by End User

• 7.1. Introduction
• 7.2. Fertility Clinics
• 7.3. Hospitals
• 7.4. Research Institutes
• 7.5. Surgical Centers

8. Fertility Services Market, by Fertility Treatment

• 8.1. Introduction
• 8.2. IUI
• 8.3. IVF
• 8.4. Medication
• 8.5. Surgery

9. Fertility Services Market, by Technology

• 9.1. Introduction
• 9.2. Artificial Insemination
• 9.3. Frozen Embryo Transfer (FET)
• 9.4. IVF ICSI
• 9.5. Pre-Implantation Genetic Diagnosis (PGD)

10. Americas Fertility Services Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Fertility Services Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Fertility Services Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Aspira Women's Health Inc.
• 3. Celmatix Inc.
• 4. Cook Medical Group, Inc.
• 5. CooperSurgical, Inc.
• 6. Ferring Pharmaceuticals
• 7. FUJIFILM Irvine Scientific, Inc.
• 8. Genea Limited
• 9. Illumina, Inc.
• 10. Irvine Scientific Sales Company, Inc.
• 11. Kaiser Permanente
• 12. Mayo Clinic
• 13. Merck KGaA
• 14. Natera, Inc.
• 15. Prelude Fertility, Inc.
• 16. Progyny, Inc.
• 17. Thermo Fisher Scientific Inc.
• 18. Vitrolife AB